Hints and tips:
...Little by little, it’s stealing our lives,” write Cross and Dillon in this highly relatable analysis of the problem — and guide to how to rise above it....
...Cross and Dillon identified that most people could find three to five opportunities to shift the effect of microstress. But where do you start?...
...In some ways, the current crop of books about depression repeats a generic tendency whose best expression may have been Andrew Solomon’s The Noonday Demon (2001)....
...Written with James Allworth and Karen Dillon, it built on a talk that Christensen used to give to students at the end of their MBA course, about how to manage their lives and careers....
...Matt Dillon, in the performance of his life, plays a serial killer for whom murder is a form of sustenance and regeneration....
...Its follow-up, May Your Kindness Remain, is even better — one of this year’s best albums — and Andrews and her band did it justice....
...Earlier this year, Sir Andrew Dillon, chief executive of Nice, said the proposals were designed to “address the challenge of providing faster access to innovative, cost-effective treatments alongside the...
...The 100-Year Life: Living and Working in an Age of Longevity, by Lynda Gratton and Andrew Scott, Bloomsbury, RRP£18.99/$28 One of the first in what will doubtless be a wave of books about how to cope with...
...Sir Andrew Dillon, Nice chief executive, said the body had made “some important changes” to the original proposals....
...Competing with Luck: The Story of Innovation and Customer Choice by Clayton Christensen, Taddy Hall, Karen Dillon and David Duncan (Harper Business, $29.99)...
...Sir Andrew Dillon, Nice chief executive, says there is a simple remedy: companies should drop their prices....
...Sir Andrew Dillon, Nice chief executive, was “disappointed” not to recommend abiraterone but said “the current cost does not appear to justify its advantages, to patients, over current standard treatment...
...asks Andrew Bates, head of financial services at Dillon Eustace....
...“The cost to the NHS of using this new drug isn’t consistent with the benefits that patients for whom it works will gain,” said Sir Andrew Dillon, Nice chief executive....
...“The question is how to balance investing in the cutting edge of medicine with more routine care,” said Sir Andrew Dillon, Nice chief executive....
...In a draft decision announced by the National Institute for Health and Care Excellence on Thursday, Sir Andrew Dillon, chief executive of the agency, said Soliris offered a “step change” in management of...
...Sir Andrew Dillon, chief executive of Nice, said the proposed review offered a chance for the pharmaceuticals industry to “reset” its relationship with the agency and the NHS....
...Last month, Sir Andrew Dillon, Nice chief executive, announced plans for a wide-ranging review of “innovation, evaluation and adoption” of new drugs in the NHS....
...Sir Andrew Dillon, Nice chief executive, acknowledges that the UK will have to rethink how it judges the value of drugs as scientific advances combine with an ageing population to place increasing strain...
...Nice had insisted this would not be allowed to happen, but in Kendal Sir Andrew Dillon, the agency’s chief executive, said there was so little agreement on the best way forward that a more broad-ranging...
...Amid a row over its rejection of life-extending cancer medicines, Sir Andrew Dillon, chief executive of the National Institute for Health and Care Excellence, said the NHS would never be able to afford every...
...Sir Andrew Dillon, Nice chief executive, said he was “really disappointed” with Roche’s inflexibility....
...Sir Andrew Dillon, Nice chief executive, suggested in an interview with the Financial Times last week that, once the CDF expired, a new way should be found to evaluate drugs....
...Putting a value on medical treatments Sir Andrew Dillon, chief executive of UK National Institute for Health and Care Excellence (Nice) There is no universal truth in valuing new medicines....
...Sir Andrew Dillon, Nice’s chief executive, said: “It’s a matter for the government to decide how to allocate NHS resources.”...
International Edition